DIVYA MITCHELL: Open Payments
NPI 1487323994 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 22 payments from 13 companies in 2025. Trend: 2023 $314 · 2024 $21 · 2025 $594
Food & beverage: $495Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $166 |
| Merck Sharp & Dohme LLC | 5 | $142 |
| Genentech USA, Inc. | 2 | $43 |
| Eisai Inc. | 2 | $41 |
| Coherus Oncology, Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Amgen Inc. | 1 | $21 |
Products named: LYNPARZA, KEYTRUDA, IMFINZI, Lenvima, LOQTORZI, WELIREG, Trodelvy, ULTOMIRIS.
Industry payments across GA — which companies pay providers there.
